Retinoblastoma function is a better indicator of cellular phenotype in cultured breast adenocarcinoma cells than retinoblastoma expression

Experimental Biology and Medicine

Volumn 227, Issue 5, 2002, Pages 354-362

  Botos, Jeannine ^a,c   Smith III, Roger ^b   Kochevar, Deborah T ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast adenocarcinoma; Cell cycle; Gene expression; Gene regulation; Retinoblastoma

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE FUNCTION; HUMAN; HUMAN CELL; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036585606     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222700508     Document Type: Article

References (55)

1. Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329:642-645, 1987.
2. Kanoe H, Nakayama T, Murakami H, Hosaka T, Yamamoto H, Nakashima Y, Tsuboyama T, Nakmura T, Sasaki MS, Toguchida J. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Anticancer Res 18:2317-2322, 1998.
3. Gope R, Gope ML. Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol Cell Biochem 110:123-133, 1992.
4. Mack PC, Chi SG, Meyers FJ, Stewart SL, deVere White RW, Gumerlock PH. Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate 34:145-151, 1998.
5. Varley JM, Armour J, Swallow JE, Jeffreys AJ, Ponder BJ, T'Ang A, Fung YK, Brammar WJ, Walker RA. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 4:725-729, 1989.
6. Horowitz JM, Park SH, Bogenmann E, Cheng JC, Yandell DW, Kaye FJ, Minna, JD, Dryja TP, Weinberg RA. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A 87:2775-2779, 1990.
7. Fung YK, T'Ang A: The role of the retinoblastoma gene in breast cancer development. In: Dickinson RB, Lippman ME, Eds. Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer. Boston: Kluwer Academic Publishers, pp59-68, 1991.
8. Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer 31A:329-333, 1995.
9. Taylor CR, Cote RJ. Immunohistochemical markers of prognostic value in surgical pathology. Histol Histopathol 12:1039-1055, 1997.
10. Sellers WR, Kaelin WG. RB as a modulator of transcription. Biochim Biophys Acta 1288:M1-M5, 1996.
11. Dyson N. The regulation of E2F by pRb-family proteins. Genes Dev 12:2245-2262, 1998.
12. Krek W, Livingston DM, Shirodkar S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557-1560, 1993.
13. Helin K, Harlow E, Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501-6508, 1993.
14. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601, 1998.
15. Magnaghi-Jaulin L, Groissman R, Naguilbneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-604, 1998.
16. Luo RX, Postigo AA, Dean DC. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473, 1998.
17. Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57:2229-2237, 1997.
18. Gottardis MM, Saceda M, Garcia-Morales P, Fung YK, Solomon H, Sholler, PF, Lippman ME, Martin MB. Regulation of retinoblastoma gene expression in hormone-dependent breast cancer. Endocrinology 136:5659-5665, 1995.
19. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086, 1990.
20. Soule HD, Vazquez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1416, 1973.
21. Cailleau R, Young R, Olive M, Reeves WJ Jr. Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661-674, 1974.
22. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A 90:1112-1116, 1993.
23. Musgrove EA, Lilischkis R, Cornish AL, Lee CS, Setlur V, Seshadri R, Sutherland RL. Expression of the cyclin-dependent kinase inhibitors p161NK4, p151NK4B and p21WAF1/CIP1 in human breast cancer. Int J Cancer 63:584-591, 1995.
24. Zhou J-N, Linder S. Expression of CDK inhibitor genes in immortalized and carcinoma-derived breast cell lines. Anticancer Res 16:1931-1936, 1996.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
26. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee WH. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci U S A 87:7762-7766, 1990.
27. Mitchell DM, Kochevar DT. The effect of sterols and Brefeldin A on protein degradation in UT-1 cells. Exp Cell Res 216:135-142, 1995.
28. Lowry O. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951.
29. Chomzynski P, Sacchi N. Single method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
30. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Alberts AS, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646, 1986.
31. Ausubel FM, Brent R, Kingston RE, Moore DD. Current Protocols in Molecular Biology. New York: John Wiley & Sons, 1993.
32. T'Ang A, Varley JM, Chakraborty R, Murphree AL, Fung YK. Structural rearrangements of the retinoblastoma gene in human breast carcinoma. Science 242:263-266, 1988.
33. Cowell JK, Bia B, Akoulitchev A. A novel mutation in the promoter region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene. Oncogene 12:431-436, 1996.
34. Gill RM, Hamel PA, Zhe J, Zacksenhaus E, Gallie BL, Phillips RA. Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ 5:467-474, 1994.
35. Hong FD, Huang HJ, To H, Young LJ, Oro A, Bookstein R, Lee EY, Lee WH. Structure of the human retinoblastoma gene. Proc Natl Acad Sci U S A 86:5502-5506, 1989.
36. Chen WD, Otterson G, Lipkowitz S, Khleif SN, Coxon A, Kaye F. Apoptosis is associated with cleavage of a 5-kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene 14:1243-1248, 1997.
37. Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K, Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci U S A 93:15215-15220, 1996.
38. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166, 1992.
39. Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 9:585-593, 1998.
40. Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRb in response to cell cycle reentry. Mol Cell Biol 16:1436-1449, 1996.
41. Pierce AM, Schneider-Broussard R, Philhower JL, Johnson DG. Differential activities of E2F family members: unique functions in regulating transcription. Mol Carcinog 22:190-198, 1998.
42. Shekhar PVM, Chen ML, Werdell J, Heppner GH, Miller FR, Christman JK. Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer. Int J Oncol 13:907-915, 1998.
43. Wang J, Sampath A, Raychaudhuri P, Bagchi S. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Oncogene 20:4740-4749, 2001.
44. Gonzalez SL, Stremlau, M, He X, Basile JR, Munger K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type E7 oncoprotein is important for functional inactivation and is separable from proteosomal degradation of E7. J Virol 75:7583-7591, 2001.
45. Blanchette P, Gilchrist CA, Baker RT, Gray DA. Association of UNP, a ubiquitin-specific protease, with the pocket proteins pRb, p107 and p130. Oncogene 20:5533-5537, 2001.
46. DeSalle LM, Latres, E, Lin D, Graner E, Montagnoli A, Baker RT. Pagano M, Loda M. The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein. Oncogene 20:5538-5542, 2001.
47. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR, Dickson RB. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150:534-544, 1992.
48. Paine TM, Soule HD, Pauley RJ, Dawson PJ. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int J Cancer 50:463-473, 1992.
49. Sommers CL, Walker-Jones D, Heckford SE, Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach S, Gelmann EP. Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 49:4258-4263, 1989.
50. Rose HN, McGrath CM, α-Lactalbumin production in human mammary carcinoma. Science 191:673-675, 1975.
51. Horwitz KB, Zava DT, Thilagar AK, Jensen EM, McGuire WL. Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res 38:2434-2437, 1978.
52. Planas-Silva MD, Weinberg RA. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol 17:4059-4069, 1997.
53. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753-761, 1998.
54. Zarkowska T, Mitmacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272:12738-12746, 1997.
55. Nelson DA, Ludlow JW. Characterization of the mitotic phase pRb directed protein phosphatase activity. Oncogene 14:2407-2415, 1997.